{"id":"NCT02025621","sponsor":"Tenax Therapeutics, Inc.","briefTitle":"Levosimendan in Patients With Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery On Cardiopulmonary Bypass","officialTitle":"A Double-Blind, Randomized, Placebo-Controlled Study of Levosimendan in Patients With Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-07","primaryCompletion":"2016-11","completion":"2016-11","firstPosted":"2014-01-01","resultsPosted":"2018-05-22","lastUpdate":"2018-06-21"},"enrollment":882,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"PREVENTION"},"conditions":["Coronary Artery Bypass Grafting","Mitral Valve Surgery","Low Cardiac Output Syndrome"],"interventions":[{"type":"DRUG","name":"Levosimendan","otherNames":["Simdax"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Levosimendan","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"A study to evaluate levosimendan compared with placebo in reducing the composite event rate of all-cause death, perioperative MI, need for new dialysis, or use of mechanical assist (IABP, LVAD or ECMO) in subjects with reduced ejection fraction undergoing cardiac surgery on cardiopulmonary bypass (CPB).","primaryOutcome":{"measure":"Number of Dual Efficacy Endpoint Events","timeFrame":"30 days","effectByArm":[{"arm":"Levosimendan","deltaMin":56,"sd":null},{"arm":"Placebo","deltaMin":48,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":19},"locations":{"siteCount":60,"countries":["United States","Canada"]},"refs":{"pmids":["35263653","28316276","27914501","25989324","25734940"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":34,"n":428},"commonTop":["Hypotension","Atrial fibrillation/flutter","Acute kidney injury","Ventricular tachycardia/fibrillation","Thrombocytopenia"]}}